Zealand Pharma A/S (ZLDPF)
35.64
-1.90
(-5.05%)
USD |
OTCM |
Oct 09, 16:00
Zealand Pharma Free Cash Flow : -253.76M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -253.76M |
| March 31, 2026 | 972.15M |
| December 31, 2025 | 1.007B |
| September 30, 2025 | 1.160B |
| June 30, 2025 | 1.149B |
| March 31, 2025 | -172.74M |
| December 31, 2024 | -133.92M |
| September 30, 2024 | -103.82M |
| June 30, 2024 | -78.11M |
| March 31, 2024 | -69.91M |
| December 31, 2023 | -65.35M |
| September 30, 2023 | -110.68M |
| June 30, 2023 | -109.91M |
| March 31, 2023 | -114.10M |
| December 31, 2022 | -133.94M |
| September 30, 2022 | -141.09M |
| June 30, 2022 | -154.94M |
| March 31, 2022 | -177.67M |
| December 31, 2021 | -189.66M |
| September 30, 2021 | -187.94M |
| June 30, 2021 | -174.77M |
| March 31, 2021 | -138.30M |
| December 31, 2020 | -109.82M |
| September 30, 2020 | -91.90M |
| June 30, 2020 | -98.66M |
| Date | Value |
|---|---|
| March 31, 2020 | -103.18M |
| December 31, 2019 | -63.92M |
| September 30, 2019 | -61.15M |
| June 30, 2019 | -52.36M |
| March 31, 2019 | -49.19M |
| December 31, 2018 | -71.99M |
| September 30, 2018 | -66.36M |
| June 30, 2018 | -52.30M |
| March 31, 2018 | -52.96M |
| December 31, 2017 | -45.24M |
| September 30, 2017 | -11.13M |
| June 30, 2017 | -16.36M |
| March 31, 2017 | -7.460M |
| December 31, 2016 | 6.323M |
| September 30, 2016 | -17.24M |
| June 30, 2016 | -19.62M |
| March 31, 2016 | -18.78M |
| December 31, 2015 | -34.15M |
| September 30, 2015 | -33.77M |
| June 30, 2015 | -23.68M |
| March 31, 2015 | -24.47M |
| December 31, 2014 | -8.001M |
| September 30, 2014 | -10.17M |
| June 30, 2014 | -19.00M |
| March 31, 2014 | -16.02M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Genmab A/S | 869.04M |
| Ascendis Pharma A/S | 388.83M |
| Bavarian Nordic A/S | 168.82M |
| Evaxion AS | -- |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 63.85M |
| Cash from Investing (Quarterly) | 34.81M |
| Cash from Financing (Quarterly) | -67.67M |
| Free Cash Flow Per Share (Quarterly) | 0.8715 |
| Free Cash Flow to Equity (Quarterly) | 62.66M |
| Free Cash Flow to Firm (Quarterly) | 63.51M |
| Free Cash Flow Yield | -10.09% |